Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4087) 4087
Conference Proceeding (79) 79
Dissertation (46) 46
Book Chapter (18) 18
Newspaper Article (13) 13
Publication (10) 10
Government Document (9) 9
Magazine Article (7) 7
Reference (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lutetium (1741) 1741
science & technology (1513) 1513
physical sciences (875) 875
physics (677) 677
materials science (606) 606
chemistry (599) 599
technology (590) 590
humans (575) 575
life sciences & biomedicine (463) 463
animals (424) 424
radioisotopes (408) 408
lutetium isotopes (393) 393
lutetium - chemistry (322) 322
exact sciences and technology (306) 306
tumors (305) 305
yttrium (300) 300
mice (291) 291
lutetium compounds (289) 289
radiology, nuclear medicine & medical imaging (276) 276
lutetium - therapeutic use (272) 272
materials science, multidisciplinary (266) 266
male (252) 252
crystals (239) 239
rare earths (232) 232
radiation therapy (225) 225
ytterbium (222) 222
radioisotopes - therapeutic use (217) 217
cerium (214) 214
female (214) 214
gadolinium (213) 213
samarium (198) 198
crystal structure (196) 196
luminescence (195) 195
europium (194) 194
nuclear medicine (193) 193
lanthanum (190) 190
rare earth metals (189) 189
erbium (183) 183
cancer (180) 180
engineering (177) 177
lutetium oxide (173) 173
patients (167) 167
physics, applied (167) 167
prostate cancer (167) 167
dysprosium (165) 165
nuclear physics and radiation physics (163) 163
terbium (163) 163
tissue distribution (163) 163
positron emission tomography (158) 158
thulium (158) 158
energy levels (155) 155
x-ray diffraction (155) 155
cell line, tumor (153) 153
chemistry, physical (153) 153
analysis (152) 152
dosimetry (147) 147
radiopharmaceuticals - therapeutic use (147) 147
oncology (146) 146
medical imaging (144) 144
metastases (144) 144
rare earth compounds (143) 143
chemistry, multidisciplinary (142) 142
holmium (141) 141
prostate (139) 139
tomography (138) 138
computed tomography (137) 137
metals (136) 136
neodymium (132) 132
ligands (129) 129
radioisotopes - chemistry (126) 126
spectra (126) 126
isotopes (124) 124
optical properties (122) 122
peptides (122) 122
kidneys (120) 120
positron emission (120) 120
inorganic, organic, physical and analytical chemistry (119) 119
lutetium, lu (119) 119
spectroscopy (119) 119
toxicity (119) 119
lutetium oxides (116) 116
physics, condensed matter (116) 116
lutetium - pharmacokinetics (115) 115
metastasis (115) 115
optics (115) 115
neuroendocrine tumors (114) 114
structure (114) 114
oxides (113) 113
nuclei (111) 111
elements (110) 110
middle aged (107) 107
chemistry, inorganic & nuclear (105) 105
condensed matter: electronic structure, electrical, magnetic, and optical properties (103) 103
octreotide - analogs & derivatives (101) 101
radiopharmaceuticals - pharmacokinetics (101) 101
synthesis (101) 101
ions (100) 100
radioimmunotherapy (100) 100
dosimeters (98) 98
scandium (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4216) 4216
German (46) 46
Japanese (29) 29
Chinese (16) 16
French (13) 13
Russian (8) 8
Dutch (2) 2
Norwegian (2) 2
Portuguese (2) 2
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer
by Tagawa, Scott T and Vallabhajosula, Shankar and Christos, Paul J and Jhanwar, Yuliya S and Batra, Jaspreet S and Lam, Linda and Osborne, Joseph and Beltran, Himisha and Molina, Ana M and Goldsmith, Stanley J and Bander, Neil H and Nanus, David M
Cancer, ISSN 0008-543X, 08/2019, Volume 125, Issue 15, pp. 2561 - 2569
prostate cancer | radioimmunotherapy | prostate‐specific membrane antigen | monoclonal antibody | Life Sciences & Biomedicine | Oncology | Science & Technology | Radioisotopes - therapeutic use | Prostatic Neoplasms, Castration-Resistant - radiotherapy | Humans | Middle Aged | Male | Radioisotopes - pharmacology | Neoplasm Metastasis | Dose Fractionation, Radiation | Lutetium - pharmacology | Survival Analysis | Aged, 80 and over | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Lutetium - therapeutic use | Thrombocytopenia | Antigens | Fractionation | Medical imaging | Toxicity | Radiation | Metastasis | Survival | Lutetium | Constraining | Metastases | Confidence intervals | Castration | Lutetium isotopes | Monoclonal antibodies | Myelosuppression | Prostate cancer | Prostate | Tumors | Neutropenia | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
by Neil H. Bander and Matthew I. Milowsky and David M. Nanus and Lale Kostakoglu and Shankar Vallabhajosula and Stanley J. Goldsmith
Journal of clinical oncology, ISSN 0732-183X, 07/2005, Volume 23, Issue 21, pp. 4591 - 4601
Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Antibodies, Monoclonal - toxicity | Prostatic Neoplasms - radiotherapy | Radioisotopes - pharmacokinetics | Humans | Middle Aged | Male | Neoplasm Metastasis - diagnostic imaging | Lutetium - administration & dosage | Lutetium - toxicity | Aged, 80 and over | Radioisotopes - toxicity | Lutetium - therapeutic use | Antibodies, Monoclonal - immunology | Bone Marrow - drug effects | Lutetium - pharmacokinetics | Prostate-Specific Antigen - administration & dosage | Radioisotopes - therapeutic use | Antibodies, Monoclonal - pharmacokinetics | Prostate-Specific Antigen - toxicity | Antibodies, Monoclonal - administration & dosage | Radionuclide Imaging | Radioisotopes - administration & dosage | Prostate-Specific Antigen - pharmacokinetics | Aged | Cell Membrane - immunology | Prostate-Specific Antigen - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
by Bodei, Lisa and Bodei, Lisa and Kidd, Mark and Kidd, Mark and Paganelli, Giovanni and Paganelli, Giovanni and Grana, Chiara M and Grana, Chiara M and Drozdov, Ignat and Drozdov, Ignat and Cremonesi, Marta and Cremonesi, Marta and Lepensky, Christopher and Lepensky, Christopher and Kwekkeboom, Dik J and Kwekkeboom, Dik J and Baum, Richard P and Baum, Richard P and Krenning, Eric P and Krenning, Eric P and Modlin, Irvin M and Modlin, Irvin M
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 1/2015, Volume 42, Issue 1, pp. 5 - 19
PRRT | Medicine & Public Health | Orthopedics | Oncology | Bone marrow toxicity | Nuclear Medicine | Imaging / Radiology | Cardiology | NET | Nephrotoxicity | Decision tree analysis | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - etiology | Neuroendocrine Tumors - diagnosis | Lutetium - administration & dosage | Yttrium Radioisotopes - administration & dosage | Aged, 80 and over | Adult | Female | Lutetium - therapeutic use | Octreotide - administration & dosage | Child | Yttrium Radioisotopes - therapeutic use | Lutetium - adverse effects | Yttrium Radioisotopes - adverse effects | Octreotide - adverse effects | Radiation Dosage | Octreotide - therapeutic use | Myelodysplastic Syndromes - etiology | Radiopharmaceuticals - administration & dosage | Neuroendocrine Tumors - radiotherapy | Adolescent | Aged | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Receptors, Peptide - metabolism | Hypertension | Hemoglobin | Leukemia | Clinical trials | Neurology | Peptides | Neurons | Endocrine system | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Ligand field effect for Dysprosium(III) and Lutetium(III) adsorption and EXAFS coordination with novel composite nanomaterials
by Awual, Md. Rabiul and Alharthi, Nabeel H and Okamoto, Yoshihiro and Karim, Mohammad Rezaul and Halim, Md. Ershad and Hasan, Md. Munjur and Rahman, Mohammed M and Islam, Md. Mominul and Khaleque, Md. Abdul and Sheikh, Md. Chanmiya
Chemical engineering journal (Lausanne, Switzerland : 1996), ISSN 1385-8947, 07/2017, Volume 320, pp. 427 - 435
EXAFS coordination | Hybrid Lewis base | Adsorption | Dysprosium(III) & Lutetium(III) | Ligand field effect | Engineering | Engineering, Chemical | Engineering, Environmental | Technology | Science & Technology | Rare earth metals | Aluminum compounds | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A novel glucose sensor using lutetium phthalocyanine as redox mediator in reduced graphene oxide conducting polymer multifunctional hydrogel
by Al-Sagur, H and Komathi, S and Khan, M.A and Gurek, A.G and Hassan, A
Biosensors & bioelectronics, ISSN 0956-5663, 06/2017, Volume 92, pp. 638 - 645
Glucose biosensor | Multifunctional hydrogel | Reduced graphene oxide | Polyaniline | Lutetium phthalocyanine | Polyacrylic acid | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Electrochemistry | Science & Technology - Other Topics | Biophysics | Chemistry, Analytical | Biotechnology & Applied Microbiology | Science & Technology | Glucose Oxidase - chemistry | Enzymes, Immobilized - chemistry | Limit of Detection | Hydrogel, Polyethylene Glycol Dimethacrylate - chemistry | Blood Glucose - analysis | Oxidation-Reduction | Humans | Oxides - chemistry | Biosensing Techniques - methods | Electrochemical Techniques - methods | Lutetium - chemistry | Aniline Compounds - chemistry | Graphite - chemistry | Indoles - chemistry | Oxidases | Usage | Phthalocyanins | Polymerization | Glucose | Dextrose | Graphene | Analysis | Graphite | Polymer industry | Sensors | Polymers | Electric properties | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Preparation and cellular-interaction investigation of 177Lu/FITC labeled NGR peptides
by Ding, Zhikai and Fu, Huaxia and Li, Xiangyu and Wang, Jing and Zhuo, Liangang and Liao, Wei and Yang, Yuchuan and Wei, Hongyuan and Yang, Xia and Chen, Yue
Journal of radioanalytical and nuclear chemistry, ISSN 0236-5731, 07/2020, Volume 325, Issue 1, pp. 67 - 74
Peptides | Lutetium isotopes | Cell membranes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Controlled synthesis and photoluminescence behaviors of Lu2O3:Eu and Lu2O2S:Eu phosphor particles
by Xu, Xinxin and Lu, Bin and Hu, Jianxu and Sun, Zhigang and Chen, Hongbing
Journal of luminescence, ISSN 0022-2313, 11/2019, Volume 215, p. 116702
Lutetium oxysulfide | Lifetime | Quantum efficiency | Lutetium oxide | Photoluminescence | Red phosphor | Eu3+ dopant | Optics | Physical Sciences | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Luminescence study of the LuBO3 and LuPO4 doped with RE3
by Mikhailin, V.V and Spassky, D.A and Kolobanov, V.N and Meotishvili, A.A and Permenov, D.G and Zadneprovski, B.I
Radiation measurements, ISSN 1350-4487, 03/2010, Volume 45, Issue 3-6, pp. 307 - 310
Lutetium phosphate | Lutetium borate | Luminescence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma
by Stillebroer, Alexander B and Boerman, Otto C and Desar, Ingrid M.E and Boers-Sonderen, Marije J and van Herpen, Carla M.L and Langenhuijsen, Johannes F and Smith-Jones, Peter M and Oosterwijk, Egbert and Oyen, Wim J.G and Mulders, Peter F.A
European urology, ISSN 0302-2838, 2012, Volume 64, Issue 3, pp. 478 - 485
Urology | Renal cell carcinoma | cG250 | Lutetium | Radioimmunotherapy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Kidneys | Nephrology. Urinary tract diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kidney Neoplasms - immunology | Antibodies, Monoclonal - therapeutic use | Male | Carcinoma, Renal Cell - immunology | Tissue Distribution | Radiopharmaceuticals - metabolism | Netherlands | Time Factors | Carbonic Anhydrases - immunology | Immunoconjugates - therapeutic use | Adult | Carcinoma, Renal Cell - enzymology | Female | Whole Body Imaging | Lutetium - therapeutic use | Lutetium - adverse effects | Carbonic Anhydrase IX | Immunoconjugates - adverse effects | Carcinoma, Renal Cell - diagnostic imaging | Antigens, Neoplasm - immunology | Immunoconjugates - metabolism | Treatment Outcome | Tumor Burden | Kidney Neoplasms - radiotherapy | Disease Progression | Carcinoma, Renal Cell - radiotherapy | Maximum Tolerated Dose | Kidney Neoplasms - diagnostic imaging | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - enzymology | Radionuclide Imaging | Kidney Neoplasms - pathology | Aged | Radiopharmaceuticals - adverse effects | Antibodies, Monoclonal - metabolism | Dose-Response Relationship, Radiation | Radioimmunotherapy - adverse effects | Radiopharmaceuticals - therapeutic use | Lutetium - metabolism | Rare earth metals | Medical research | Care and treatment | Monoclonal antibodies | Medicine, Experimental | Carcinoma, Renal cell | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Metal‐Size Influence in Iso‐Selective Lactide Polymerization
by Bakewell, Clare and White, Andrew J. P and Long, Nicholas J and Williams, Charlotte K
Angewandte Chemie (International ed.), ISSN 1433-7851, 08/2014, Volume 53, Issue 35, pp. 9226 - 9230
lutetium | iso‐selectivity | ring‐opening polymerization | lactide | lanthanum | iso-selectivity | ring-opening polymerization | Rare earth metals | Polymerization | Covalence | Derivatives | Initiators | Lutetium | Communications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Lutetium-177 tin colloid radiosynovectomy in patients with inflammatory knee joint conditions intractable to prevailing therapy
by Jha, Pragati and Arora, Geetanjali and Shamim, Shamim A and Mukherjee, Anirban and Gautam, Deepak and Ballal, Sanjana and Kumar, Uma and Ansari, Tahir M and Bal, Chandrasekhar
Nuclear medicine communications, ISSN 0143-3636, 07/2018, Volume 39, Issue 9, pp. 803 - 808
lutetium | tin colloid | radiosynovectomy | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radioisotopes - therapeutic use | Colloids | Humans | Radioisotopes - adverse effects | Male | Synovectomy - methods | Osteoarthritis, Knee - therapy | Knee Joint - surgery | Tin - chemistry | Treatment Failure | Adult | Female | Lutetium - chemistry | Synovectomy - adverse effects | Lutetium - therapeutic use | Osteoarthritis, Knee - surgery | Lutetium - adverse effects |